Degree	University	Country	Year
Diplôme - Soins palliatifs et accompagnement en gériatrie	Université de Rennes I	France	2018
Diplôme - Médecine	Université de Rennes I	France	2016
Diplôme de spécialisation - Hématologie	Université de Rennes I	France	2015
Diplôme - Médecine	Université Claude Bernard (Lyon I)	France	2014
M1 - biologie	Université de Rennes I	France	2014
Certificat - Thérapeutiques des édentations totales	Université de Lille	France	2010

Septembre 2014: Poster au congrès COMETH-GEHT Haemostasis Congress: Atypical thrombosis and mutations of the CALR Mai 2015: Poster au congrès de la SFH (French Society of Haematology): Incidence of CALR mutations in intra-abdominal thrombosis and cerebral thrombophlebitis Décembre 2016: Poster au congrès American Society of Haematology (ASH) Conference: The Place of Adjuvant Chemotherapy in the Treatment of Solitary Bone Plasmacytoma Mars 2017: Poster au congrès de la SFH : La place de la chimiothérapie adjuvante dans le traitement du plasmocytome solitaire osseux Mars 2017: Publication de l’article: Traitement de première ligne du lymphome folliculaire in the review Horizons Hémato Janvier 2018: publication du chapitre: Standard of care of relapsed DLBCL : Springer Book - Lenz / Rooms - Aggressive Lymphomas Mars 2019: publication de l’article: Impact of the relative dose intensity on survival of patients with high-risk myelodysplastic syndromes treated with Azacitidine- Cancer Medecine. DOI : 10.1002/cam4.2121 Avril 2019: publication de l’article: « New insights in the treatment of patients with solitary bone plasmacytoma » Publication in Leukemia-Lymphoma journal. DOI : 10.1080/10428194.2019.1605067 Janvier 2020: Prix Meilleur chercheur a l’hopital du Mans -France: study CITAC- Research project with the Infectious Diseases Department on Central Catheter Infections: Incidence and Management of Septic Thrombosis Décembre 2020: Case report: COVID-19 patient with secondary hemophagocytic lymphohistiocytosis (sHLH) -Presentation Arab Health conférence 2021 Janvier 2022: publication in Clinics and Practice: Establishment of the First Comprehensive Adult and Pediatric Hematopoietic Stem Cell Transplant Unit in the United Arab Emirates: Rising to the Challenge. DOI: 10.3390/clinpract12010010 Aout 2023 : publication de l’article : “Explosive disease progression after single agent B-cell Maturation Antigen-Targeted treatment in Multiple Myeloma: Sheikh Shakhbout Medical City -A case series” - DOI: 10.7759/cureus.44433. Septembre 2024: The hidden truth from mycosis fungoides to NK T Cell lymphoma A case report Ahmed Medhat Eldimllawi; Islam Samir Elkonaissi; Fatima Ahmed Abdullah Al Hasani; Mohamed AOsman; Aseel Suleiman Mohieldin Al-Sayed; Husni Alhateeti; Kayane Mheidly Open Journal of Clinical and Medical Case Reports 10(21) DOI:10.52768/2379-1039/2288 Novembre 2024: Paving the Road for Haematopoietic Stem Cell Transplantation in the United Arab Emirates: A Single Centre’s Experience Kaloyannidis P, George B, Alrustamani A, Khalil C, Al-Charfli B, Al-Moghrabi N, Ibrahim D, Alfar M, Daryahya M, Mheidly K, El-Saddik A, Al-Shamsi HO Journal of Blood Medicine 2024, 15:471-475 Fevrier 2024: Genome Engineering as a Therapeutic Approach in Cancer Therapy: A Comprehensive Review DOI:10.1002/ggn2.202300201 Fevrier 2025: Upfront fixed-duration treatment strategies for chronic lymphocytic leukemia in Arab populations: a position statement from the Gulf region Frontiers in Medicine DOI:10.3389/fmed.2025.1509074 Fevrier 2025: Frontline management of multiple myeloma patients: optimizing treatment for patients in the Gulf region • DOI: 10.46989/001c.128113 Mars 2025: P003: TRENDS AND DEMOGRAPHICS OF STEM CELL TRANSPLANTATION IN THE UNITED ARAB EMIRATES: A RETROSPECTIVE ANALYSIS FROM THREE MAJOR TERTIARY CARE HOSPITALS (2009-2023) DOI:10.13140/RG.2.2.26649.74080 Conference: EBMT 2025 May 2025: Relapsed/refractory multiple myeloma: standard of care management of patients in the Gulf region DOI: 10.46989/001c.137860